HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Behavioral, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to develop and evaluate an Artificial Intelligence Assisted Prehabilitation Program (AI APP) for returning to work and cost-effectiveness analysis in patients with oral cancer (OC). The main questions it aims to answer are: * What kinds of needs are related to returning to work (RTW) in patients with OC from diagnosis to survival that we can incorporate into the development of AI APP to assist this population ? * How is the effect of the AI APP that based on findings from the first question for patients with OC on physical and psychological distress, fear of recurrence, self-efficacy in coping with cancer, communication, motor function, quality of life, and RTW? * How is the effect of the RTW AI prediction model to identify high-risk groups ? And how is the comprehensive cost effectiveness of benefits and quality of life of the AI APP for OC population? Researchers will compare patients without using AI APP to see if the AI APP works to assist with coping physical and psychological distress, communication, motor function, quality of life, and RTW issues for individuals with OC? Participants will: * Be asked to fulfill a structural questionnaire, or engage in a semi-structured one-by-one interview or a focus group to assess their physical, psychological, and social support needs in the first stage. * Be invited to participant the pilot testing of AI APP in the second stage. * Be provided and trained by 3-month AI APP for 3 months or cared as usual in the third stage. * Complete a structural questionnaire and follow up one year, including the baseline (before using the AI app) and at 1-2 weeks, 3 months, 6 months, 9 months, and 12 months after the baseline. * Engage in one-by-one interview or a focus group to assess user experiences of the AI APP.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 70
Healthy Volunteers: t
View:

• Adult (\> 20 years old and younger than 70 years old)

• Newly diagnosed as OC and scheduled to receive cancer-related treatment

• Able to use Mobile phone

• Willing to sign an informed consent form after receiving a detailed explanation of the study's aims and procedures

• Healthcare professionals involved in patients' care, including doctors, nurses, case managers, dietitians, rehabilitation therapists, and psychologists

• Family members who are primary caregivers of the participating patients, engaged in different stages of medical care

Locations
Other Locations
Taiwan
National Taiwan University Hospital
RECRUITING
Taipei
National Yang Ming Chiao Tung University
RECRUITING
Taipei
National Yang Ming Chiao Tung University
RECRUITING
Taipei
National Yang Ming Chiao Tung University
ENROLLING_BY_INVITATION
Taipei
Taipei Veterans General Hospital
RECRUITING
Taipei
Contact Information
Primary
Shiow-Ching Shun
scshun@nycu.edu.tw
+886-911-268-998
Time Frame
Start Date: 2024-09-27
Estimated Completion Date: 2029-12-01
Participants
Target number of participants: 650
Treatments
Active_comparator: Control group Usual care
The patients in this group will not use the AI APP. They will receive 12 times of physiotherapy and keep receiving usual care.
Experimental: Intervention group
The patients in this group will receive and use AI APP while receiving usual care.
Related Therapeutic Areas
Sponsors
Leads: Taipei Veterans General Hospital, Taiwan
Collaborators: National Yang Ming Chiao Tung University Hospital, National Taiwan University Hospital

This content was sourced from clinicaltrials.gov